Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis

<p>Abstract</p> <p>Background</p> <p>Chronic hepatitis B virus (HBV) infection represents a serious global health problem and resistance to lamivudine (LAM) has become a serious clinical challenge. Previous rescue therapy for the treatment of chronic LAM-resistant hepat...

Full description

Bibliographic Details
Main Authors: Hu Peng, Zhang Da-Zhi, Hu Huai-Dong, Tong Shi-Wen, Liu Jun-Ying, Sheng Yun-Jian, Ren Hong
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Virology Journal
Subjects:
Online Access:http://www.virologyj.com/content/8/1/393